MX380349B - Expresion de un anticuerpo de cadena sencilla contra la salmonella en lactobacillus - Google Patents

Expresion de un anticuerpo de cadena sencilla contra la salmonella en lactobacillus

Info

Publication number
MX380349B
MX380349B MX2016012597A MX2016012597A MX380349B MX 380349 B MX380349 B MX 380349B MX 2016012597 A MX2016012597 A MX 2016012597A MX 2016012597 A MX2016012597 A MX 2016012597A MX 380349 B MX380349 B MX 380349B
Authority
MX
Mexico
Prior art keywords
lactobacilli
expression
antibody against
chain antibody
against salmonella
Prior art date
Application number
MX2016012597A
Other languages
English (en)
Spanish (es)
Other versions
MX2016012597A (es
Inventor
Manisha Pravin Sabnis
Sanjiban Kumar Banerjee
Original Assignee
Sambuddha Ghosh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sambuddha Ghosh filed Critical Sambuddha Ghosh
Publication of MX2016012597A publication Critical patent/MX2016012597A/es
Publication of MX380349B publication Critical patent/MX380349B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1235—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Salmonella (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2016012597A 2014-03-27 2015-03-27 Expresion de un anticuerpo de cadena sencilla contra la salmonella en lactobacillus MX380349B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2015/000407 WO2015145250A2 (en) 2014-03-27 2015-03-27 Expression of a single chain antibody against salmonella in lactobacillus
IN1100MU2014 IN2014MU01100A (enExample) 2014-03-27 2015-03-27

Publications (2)

Publication Number Publication Date
MX2016012597A MX2016012597A (es) 2017-04-27
MX380349B true MX380349B (es) 2025-03-12

Family

ID=54196512

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012597A MX380349B (es) 2014-03-27 2015-03-27 Expresion de un anticuerpo de cadena sencilla contra la salmonella en lactobacillus

Country Status (9)

Country Link
US (1) US10544208B2 (enExample)
EP (1) EP3122773B1 (enExample)
CN (1) CN107074934B (enExample)
AU (1) AU2015237933B2 (enExample)
CA (1) CA2943903C (enExample)
IN (1) IN2014MU01100A (enExample)
MX (1) MX380349B (enExample)
MY (1) MY199990A (enExample)
WO (1) WO2015145250A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015237933B2 (en) 2014-03-27 2020-09-17 Sambuddha GHOSH Expression of a single chain antibody against Salmonella in Lactobacillus
AU2016214059B2 (en) * 2015-02-04 2021-08-05 Abcelex Technologies Inc. Anti-salmonella antibodies and uses thereof
WO2017199094A1 (en) * 2016-05-20 2017-11-23 Novobind Livestock Therapeutics Inc. Antibodies against microorganisms and uses thereof
MX2020013248A (es) * 2018-06-05 2021-04-13 Novobind Livestock Therapeutics Inc Anticuerpos contra agentes patogenos en acuacultura y sus aplicaciones.
CN108864281B (zh) * 2018-07-13 2020-09-08 西北农林科技大学 一种抗肠炎沙门氏菌的纳米抗体及其应用
EP3880701A4 (en) 2018-11-13 2022-11-02 Novobind Livestock Therapeutics, Inc. ANTIBODIES AGAINST CANINE AND CAT PATHOGENS AND THEIR USES
WO2022010417A1 (en) * 2020-07-06 2022-01-13 Singapore University Of Technology And Design 3d printing of milk-based product
CN113564095B (zh) * 2021-07-27 2023-10-20 陈玉松 外源核苷酸在促进干酪乳杆菌拮抗肠沙门氏菌方面的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
WO2003096812A1 (en) * 2002-04-15 2003-11-27 Washington University Regulated attenuation of live vaccines to enhance cross protective immunogenicity
AP2007004019A0 (en) 2004-11-25 2007-06-30 Unilever Plc Heavy chain and single domain antibodies
CN101360512A (zh) 2005-08-19 2009-02-04 荷兰联合利华有限公司 包含益生菌微生物和抗体的食物产品
CN101469333B (zh) * 2007-12-25 2014-01-22 温州医学院 一种抗沙门菌单链抗体与跨膜蛋白融合蛋白的制备方法
GB0816462D0 (en) * 2008-09-09 2008-10-15 Univ Birmingham Non-typoidal salmonella vaccines
AU2015237933B2 (en) 2014-03-27 2020-09-17 Sambuddha GHOSH Expression of a single chain antibody against Salmonella in Lactobacillus

Also Published As

Publication number Publication date
IN2014MU01100A (enExample) 2015-10-02
US20170152305A1 (en) 2017-06-01
CA2943903A1 (en) 2015-10-01
EP3122773B1 (en) 2020-07-22
WO2015145250A2 (en) 2015-10-01
WO2015145250A3 (en) 2016-01-21
AU2015237933B2 (en) 2020-09-17
CA2943903C (en) 2023-03-14
EP3122773A2 (en) 2017-02-01
CN107074934A (zh) 2017-08-18
US10544208B2 (en) 2020-01-28
BR112016022375A2 (pt) 2019-01-15
MY199990A (en) 2023-12-02
CN107074934B (zh) 2021-06-29
AU2015237933A1 (en) 2016-10-20
MX2016012597A (es) 2017-04-27
NZ725349A (en) 2024-05-31

Similar Documents

Publication Publication Date Title
MX380349B (es) Expresion de un anticuerpo de cadena sencilla contra la salmonella en lactobacillus
NI201700001A (es) Composiciones de portador-anticuerpo y métodos para realizarlas y utilizarlas
GT201700048A (es) Terapias de combinación con anticuerpos anti-cd38
AR095232A1 (es) Métodos y composiciones para el control de malezas
MX2015013104A (es) Composiciones y métodos para la inmunoterapia.
CL2019001698A1 (es) Suministro de proteínas basado en bacterias con virulencia atenuada.
IN2014DN10057A (enExample)
MX2015012334A (es) Metodos y composiciones para el control de malezas.
MX369067B (es) Método para reducir la producción de gas total y/o la producción de metano en un animal rumiante.
MX2016014862A (es) Her3 / her2 anticuerpos biespecificos que se unen a la horquilla beta de her3 y al dominio ii de her2.
EP3125938A4 (en) Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-ctla-4 and/or anti-pd-1 antibodies to treat solid tumor malignancies
MX2017008097A (es) Sintesis comercialmente viable de cantaridina y derivados bioactivos de cantaridina.
NZ730092A (en) Use of cysteamine in treating infections caused by yeasts/moulds
MX2017008668A (es) Composicion de alimentos y metodo de uso.
BR112016028948A2 (pt) ?composição bifásica?
PH12017500084A1 (en) Vitamin b2 and its use
BR112017026005A2 (pt) ?polipeptídeo, polinucleotídeo, micro-organismo do gênero escherichia, método de produção de o- acetil-homosserina e de l-metionina?
PH12016501947A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
TWD171533S (zh) 遙控器
MX376367B (es) Activacion del factor x.
UA92110U (uk) Спосіб лікування ішемії нижньої кінцівки у хворих з ускладненим синдромом діабетичної стопи
IN2013CH05311A (enExample)
UA104068C2 (en) Yoghurt
IN2014CH03785A (enExample)
TWD166210S (zh) 鞋子